Diseases and physical health conditions

This dashboard presents selected data that are relevant for monitoring the impacts of COVID-19 on economic activity in Canada. It includes data on a range of monthly indicators - real GDP, consumer prices, the unemployment rate, merchandise exports and imports, retail sales, hours worked and manufacturing sales -- as well as monthly data on aircraft movements, railway carloadings, and travel between Canada and other countries.

Estimates are presented from January 2019 to the current reference month for each data series. The information will be updated continuously as new data becomes available, and additional series may be added to the dashboard as circumstances warrant.

To support the analysis of time series movements in the data, the dashboard reports changes in each series on both a month-over-month and year-over-year basis. For most of the variables reported, information on cumulative changes in the data both prior and subsequent to the end of 2019 is also presented by indexing the level estimates to December 2019, as depicted in the accompanying charts.

In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

In collaboration with the Public Health Agency of Canada (PHAC), this data file provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary.

Canadians have been gravely impacted by the COVID-19 pandemic, and adults living with children may have been disproportionately impacted. The objective of this study was to describe changes in chronic disease risk factors and current exercise habits among adults living with and without a child younger than 18 years old.

Certain population groups face a disproportionate burden of exposure to COVID-19. This study examined characteristics of Canadians living in private households in fall 2020 and winter 2021 who had been infected with COVID-19.

Chronic conditions among seniors aged 65 and older, Canadian Health Survey on Seniors, by age group and sex, Canada (excluding territories) and provinces. This table uses two-year period estimates from the 2019/2020 pooled data. For annual estimates, see table 13-10-0788.

This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.

Number and proportion of prevalent cancer cases for two-, five-, ten- and twenty-year prevalence durations from January 1st,1994 to the most recent index date available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

This dashboard presents selected data that are relevant for monitoring the impacts of COVID-19 on economic activity in Canada. It includes data on a range of monthly indicators - real GDP, consumer prices, the unemployment rate, merchandise exports and imports, retail sales, hours worked and manufacturing sales -- as well as monthly data on aircraft movements, railway carloadings, and travel between Canada and other countries.

Estimates are presented from January 2019 to the current reference month for each data series. The information will be updated continuously as new data becomes available, and additional series may be added to the dashboard as circumstances warrant.

To support the analysis of time series movements in the data, the dashboard reports changes in each series on both a month-over-month and year-over-year basis. For most of the variables reported, information on cumulative changes in the data both prior and subsequent to the end of 2019 is also presented by indexing the level estimates to December 2019, as depicted in the accompanying charts.

In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

In collaboration with the Public Health Agency of Canada (PHAC), this table provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary. This table will provide an aggregate summary of the data available in the publication 13-26-0003.

In collaboration with the Public Health Agency of Canada (PHAC), this data file provides Canadians and researchers with preliminary data to monitor only the confirmed cases of coronavirus (COVID-19) in Canada. Given the rapidly-evolving nature of this situation, these data are considered preliminary.

Chronic conditions among seniors aged 65 and older, Canadian Health Survey on Seniors, by age group and sex, Canada (excluding territories) and provinces. This table uses two-year period estimates from the 2019/2020 pooled data. For annual estimates, see table 13-10-0788.

Number and proportion of prevalent cancer cases for two-, five-, ten- and twenty-year prevalence durations from January 1st,1994 to the most recent index date available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

This table presents a series of indicators relating to the COVID-19 pandemic, including relating to perceptions of Canadians' mental health, precautions they've taken, their experience of symptoms, and willingness to receive vaccine. Estimates are based on preliminary monthly data from the Canadian Community Health Survey, and are provided for the Canadian population aged 18 and older excluding the territories, by gender, age, region of residence, and other demographic characteristics.

Annual percent change and average annual percent change in age-standardized cancer mortality rates since 1984 to the most recent data year. The table includes a selection of commonly diagnosed invasive cancers and causes of death are defined based on the World Health Organization International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1999 and on its tenth revision (ICD-10) from 2000 to the most recent year.

Annual percent change and average annual percent change in age-standardized cancer incidence rates since 1984 to the most recent diagnosis year. The table includes a selection of commonly diagnosed invasive cancers, as well as in situ bladder cancer. Cases are defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3) from 1992 to the most recent data year and on the International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1991.

Number of deaths caused by diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, by age group and sex, 2000 to most recent year.

Canadians have been gravely impacted by the COVID-19 pandemic, and adults living with children may have been disproportionately impacted. The objective of this study was to describe changes in chronic disease risk factors and current exercise habits among adults living with and without a child younger than 18 years old.

Certain population groups face a disproportionate burden of exposure to COVID-19. This study examined characteristics of Canadians living in private households in fall 2020 and winter 2021 who had been infected with COVID-19.

This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.

Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

This document provides descriptive results of the muscle and bone density of the tibia. Descriptive results for lower limb muscle power and force are also presented.

Hypertension is a common condition experienced by close to one-quarter of the adult population in Canada. There is evidence that this condition or the medications used to treat it may lead to hearing health problems. The purpose of this study is to quantify associations between hypertension and hearing health problems—defined as having hearing loss, tinnitus or both conditions for adults aged 19 to 79 years. Data from cycles 3 (2012 to 2013) and 4 (2014 to 2015) of the Canadian Health Measures Survey are used.

This infographic provides information on the prevalence of hearing loss, tinnitus, or both conditions among Canadian adults. The prevalence of each condition is presented by sex and age group. Also included is the proportion who are unaware of their hearing loss.

This study is the first comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada. The results span the complete time period of the Canadian Cancer Registry and are unaffected by changes in the age, sex and case-mix of cancers over this time. Specifically, predicted Canadian net cancer survival index (CSI) estimates for the three-year period from 2015 to 2017 are presented and compared with corresponding actual estimates dating as far back as the 1992-to-1994 period. Comparisons are made for both sexes combined and for males and females separately. Further insight is provided by the determination of the most influential cancer and sex combinations and the leading cancer types within each sex, in regard to changes in the CSI since the periods of 1992 to 1994 and 2005 to 2007.

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

This document examines the functional limitations, physical, emotional and social, related to the musculoskeletal conditions having the largest impact on the health of Canadians. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with certain musculoskeletal conditions affects day-to-day functioning.